What is Inter Partes Review?

An inter partes review, in the trademark context, refers to an adversarial proceeding between two or more parties before a trademark office or administrative tribunal to determine the validity or registrability of a trademark. While the term "inter partes review" is most commonly associated with patent proceedings before the Patent Trial and Appeal Board (PTAB), the concept of inter partes proceedings is equally important in trademark law, encompassing oppositions, cancellations, and other contested matters heard by bodies such as the TTAB in the United States, the Boards of Appeal at the EUIPO, and equivalent tribunals in other jurisdictions.

Inter partes proceedings are distinguished from ex parte proceedings, in which only one party participates. In an ex parte trademark proceeding, such as an appeal from an examiner's refusal, only the applicant presents arguments to the tribunal. In an inter partes proceeding, both the challenger and the mark owner or applicant participate, present evidence, and make legal arguments. The adversarial nature of inter partes proceedings ensures that both sides of the dispute are fully represented.

The procedural framework for inter partes trademark proceedings varies by jurisdiction. In the United States, TTAB proceedings follow rules modeled on the Federal Rules of Civil Procedure, with adapted provisions for discovery, evidence submission, and trial on the written record. At the EUIPO, proceedings follow the European Union Trade Mark Regulation and the EUIPO Guidelines. Other offices have their own procedural rules, though common elements include written pleadings, evidence submission periods, and written or oral decisions.

Why It Matters

Inter partes proceedings are essential to maintaining the integrity of trademark registers worldwide. They provide a mechanism for third parties to challenge marks that should not have been registered or that conflict with prior rights, ensuring that the register accurately reflects legitimate trademark rights. Without these proceedings, the trademark register would be purely the product of ex parte examination, which, while thorough, cannot account for all prior rights and marketplace realities.

These proceedings also offer significant advantages over court litigation for resolving trademark disputes. They are typically less expensive, with costs ranging from tens of thousands to low hundreds of thousands of dollars compared to the often seven-figure costs of federal litigation. They are decided by specialized tribunals with deep expertise in trademark law. And they result in decisions that directly affect the trademark register, whereas a court judgment may require separate proceedings to implement changes to a registration.

The strategic significance of inter partes proceedings extends beyond individual disputes. The body of decisions produced by tribunals like the TTAB and the EUIPO Boards of Appeal constitutes a substantial body of trademark jurisprudence that shapes examination practices, counseling standards, and enforcement strategies across the profession.

How Signa Helps

Signa's platform is an essential tool for managing inter partes proceedings across multiple jurisdictions. The platform's monitoring capabilities ensure that users are aware of potentially conflicting marks during the window when opposition is available, maximizing the opportunity for inter partes challenge rather than more expensive post-registration remedies.

The platform's comprehensive trademark database supports the evidence-gathering requirements of inter partes proceedings. Whether building a case for opposition, cancellation, or defense, legal teams can use Signa to research prior registrations, ownership histories, classification details, and filing timelines across 200+ offices. This cross-jurisdictional evidence can be particularly powerful in proceedings where the strength and fame of a mark must be demonstrated.

Signa's clearance analysis tools also help users evaluate the merits of potential inter partes actions before committing resources. By providing a data-driven assessment of mark similarity, goods and services overlap, and potential for confusion, the platform helps legal teams make informed decisions about when to initiate proceedings and when to pursue alternative strategies.

Real-World Example

A pharmaceutical company, "MedCore Therapeutics," uses Signa's monitoring to track trademark activity in its industry across the globe. The platform alerts the company to three separate developments: a new application published for opposition at the USPTO, a recently registered mark at the EUIPO that is within the cancellation window, and a pending application at WIPO designating six countries where MedCore holds registrations.

Each development requires a different inter partes strategy. For the USPTO application, MedCore files an opposition before the TTAB within the 30-day window. For the EUIPO registration, the team evaluates the grounds for cancellation and the applicable time limits. For the WIPO designation, MedCore relies on national phase opposition procedures in each designated country.

Signa's platform serves as the central command center for managing all three proceedings simultaneously. The trademark data from each jurisdiction, compiled through Signa's search tools, forms the evidentiary basis for each proceeding. The monitoring system continues to track developments in each case, including status updates, new filings by the opposing parties, and deadline reminders, ensuring that no critical dates are missed across the multi-jurisdictional enforcement effort.